1656.0000 7.40 (0.45%)
NSE Sep 19, 2025 15:31 PM
Volume: 3.2M
 

1656.00
0.45%
BOB Capital Markets Ltd.
Sales/EBITDA/APAT were lower than our estimates by 3.5%/9.6%/29.4%. ETR for 4QFY25 stood at 32.9% including 1x tax expense of Rs 3.7bn
Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
More from Sun Pharmaceutical Industries Ltd.
Recommended